Company: BSX
Filing Date: 2025-02-26
Form Type: 8-K
Source: 0000885725-25-000013
Chunk: 2

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-26
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01 Other Events.

On February 26, 2025, AMS Europe completed the offering of the Notes. The net proceeds from the offering of the Notes, after deducting the underwriting discount and estimated offering expenses payable by us, were approximately €1.487 billion. The Company intends to use the net proceeds from the offering of the Notes, together with cash on hand, to fund the repayment at maturity of AMS Europe’s 0.750% Senior Notes due March 8, 2025, and to pay accrued and unpaid interest with respect to such notes, and for general corporate purposes, which may include, among other things, short term investments, reduction of short term debt, funding of working capital and potential future acquisitions.

In connection with the offering of the Notes, the Company is filing legal opinions regarding the validity of the Notes, attached as Exhibit 5.1 and Exhibit 5.2 to this Current Report on Form 8-K.

Additionally, on February 21, 2025 and February 26, 2025, the Company issued press releases pertaining to the events described in this Current Report on Form 8-K, copies of which are attached as Exhibit 99.1 and Exhibit 99.2 hereto and are hereby incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.